Document Detail


Botulinum toxin as adjunctive therapy in refractory laryngeal granuloma.
MedLine Citation:
PMID:  17908354     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: This study evaluated the role of botulinum toxin type A in the treatment of refractory laryngeal granulomas. STUDY DESIGN AND SETTING: Retrospective clinical review at a tertiary care hospital. Seven patients with vocal process granulomas underwent percutaneous injection of botulinum toxin into both vocal folds, performed in an office setting. Total doses ranged from 10 to 25 U, divided between both vocal folds. RESULTS: All patients experienced resolution of their granulomas over two to seven weeks. No patient developed aspiration pneumonia. All patients experienced hoarseness secondary to the injections, but voice quality returned to baseline in all patients as the toxin was degraded. CONCLUSIONS: Botulinum toxin is safe and effective therapy in resolving vocal process granulomas in patients refractory to traditional therapy. The optimal treatment dose remains to be determined. SIGNIFICANCE: Percutaneous botulinum toxin injection is helpful in resolving laryngeal granulomas.
Authors:
E J Damrose; J F Damrose
Related Documents :
22344584 - Worsening essential tremor following deep brain stimulation: disease progression versus...
20675764 - The effect of injections of botulinum toxin type a combined with casting on the equinus...
8502104 - Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice...
16192104 - Botulinum toxin type a treatment in neurogenetic syndromes.
2965324 - Percutaneous transluminal angioplasty for the ischaemic lower limb: the early dunedin e...
15249454 - Cytokine response to pulmonary thromboendarterectomy.
Publication Detail:
Type:  Journal Article     Date:  2007-10-02
Journal Detail:
Title:  The Journal of laryngology and otology     Volume:  122     ISSN:  1748-5460     ISO Abbreviation:  J Laryngol Otol     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-07-17     Completed Date:  2008-09-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706896     Medline TA:  J Laryngol Otol     Country:  England    
Other Details:
Languages:  eng     Pagination:  824-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Stanford University Medical Center, Stanford, CA 94305, USA. edamrose@ohns.stanford.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Botulinum Toxin Type A / administration & dosage*
Combined Modality Therapy
Drug Administration Schedule
Follow-Up Studies
Granuloma, Laryngeal / drug therapy*,  pathology,  surgery
Humans
Injections
Laryngoscopy
Male
Middle Aged
Retrospective Studies
Vocal Cords / drug effects,  pathology,  surgery
Voice Quality
Chemical
Reg. No./Substance:
0/Botulinum Toxin Type A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce ...
Next Document:  Gorlin's syndrome presenting with myolipoma of tongue base.